Title Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
Authors Yu, Xing-Xing
Shang, Qian-Nan
Liu, Xue-Fei
He, Mei
Pei, Xu-Ying
Mo, Xiao-Dong
Lv, Meng
Han, Ting-Ting
Huo, Ming-Rui
Zhao, Xiao-Su
Chang, Ying-Jun
Wang, Yu
Zhang, Xiao-Hui
Xu, Lan-Ping
Liu, Kai-Yan
Zhao, Xiang-Yu
Huang, Xiao-Jun
Affiliation Peking Univ, Peking Univ Peoples Hosp, Natl Clin Res Ctr Hematol Dis,Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China
Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
Beijing Engn Lab Cellular Therapy, Beijing, Peoples R China
Keywords HUMAN CYTOMEGALOVIRUS-INFECTION
NATURAL-KILLER-CELLS
COPY-NUMBER
RISK-FACTOR
NK CELLS
REACTIVATION
LEUKEMIA
DELETION
RECEPTOR
DISEASE
Issue Date 8-Feb-2022
Publisher JCI INSIGHT
Abstract CMV infection remains an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Several investigators have reported that adaptive NKG2C+ NK cells persistently expand during CMV reactivation. In our study, 2 cohorts were enrolled to explore the relationships among the NKG2C genotype, NKG2C+ NK cell reconstitution, and CMV infection. Multivariate analysis showed that donor NKG2C gene deletion was an independent prognostic factor for CMV reactivation and refractory CMV reactivation. Furthermore, adaptive NKG2C+ NK cells' quantitative and qualitative reconstitution, along with their anti-CMV function after transplantation, was significantly lower in patients grafted with NKG2Cwt/del donor cells than in those grafted with NKG2Cwt/wt donor cells. At day 30 after transplantation, quantitative reconstitution of NKG2C+ NK cells was significantly lower in patients with treatment-refractory CMV reactivation than in patients without CMV reactivation and those with nonrefractory CMV reactivation. In humanized CMV-infected mice, we found that, compared with those from NKG2Cwt/del donors, adaptive NKG2C+ NK cells from NKG2Cwt/wt donors induced earlier and stronger expansion of NKG2C+ NK cells as well as earlier and stronger CMV clearance in vivo. In conclusion, donor NKG2C homozygosity contributes to CMV clearance by promoting the quantitative and qualitative reconstruction of adaptive NKG2C+ NK cells after haploidentical allo-HSCT.
URI http://hdl.handle.net/20.500.11897/637987
DOI 10.1172/jci.insight.149120
Indexed SCI(E)
Appears in Collections: 人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.